Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.3410
-0.019-5.28%
At close: Aug 14, 5:00 PM EST
Kairos Pharma Ltd (KAPA) Stock Price, Quote, News & History
KAPAAMEX
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Kairos Pharma (KAPA) stock?
You can purchase shares of Kairos Pharma (AMEX:KAPA) through any online brokerage.
Who are Kairos Pharma (KAPA) competitors?
Other companies in Kairos Pharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
What is the forecast, or price target, for Kairos Pharma (KAPA) stock?
Kairos Pharma has a consensus price target of $8.50.
What is the current price for Kairos Pharma (KAPA)?
The stock price for Kairos Pharma (AMEX: KAPA) is $ last updated .
Does Kairos Pharma (KAPA) pay a dividend?
There are no upcoming dividends for Kairos Pharma.
When is Kairos Pharma (AMEX:KAPA) reporting earnings?
Kairos Pharma does not have any upcoming earnings scheduled.
Is Kairos Pharma (KAPA) going to split?
There is no upcoming split for Kairos Pharma.
What sector and industry does Kairos Pharma (KAPA) operate in?
Kairos Pharma is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
